Evidence map›Paper›PMID 16251416›Full record

ArticleThe American journal of pathology2005

Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantation.

Christoph H Schimmelpfennig, Stephan Schulz, Caroline Arber, Jeanette Baker, Ingo Tarner, Jacqueline McBride, Christopher H Contag, Robert S Negrin

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 40 citations in OpenAlex.

  1. The Immunoimaging Toolbox.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2018
    Review
  2. Article
  3. Mechanisms of dendritic cell trafficking across the blood-brain barrier.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2012
    Review
  4. Article
  5. Review
  6. In vivo imaging of immune cell trafficking in cancer.European journal of nuclear medicine and molecular imaging · 2011
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Noninvasive imaging of cell-mediated therapy for treatment of cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Christoph H SchimmelpfennigDivision of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Center for Clinical Science Building, Room 2205, 269 West Campus Dr., Stanford, CA 94305, USA.
Stephan Schulz
Caroline Arber
Jeanette Baker
Ingo Tarner
Jacqueline McBride
Christopher H Contag
Robert S Negrin
Stanford University · USStanford Blood Center · USPediatrics and Genetics · USStanford Medicine · US

Funding

Spatiotemporal Analysis of Neoplasia in Animal ModelsR24CA092862 · NCI · STANFORD UNIVERSITY · PI CONTAG, CHRISTOPHER H · 2001 to 2006
$4.4M
NCI NIH HHS R24 CA092862NCI NIH HHS R24 CA 92862
6 · The paper itself

Abstract

Little is known about adoptive transfer of allogeneic ex vivo expanded dendritic cells (eDCs). We investigated the trafficking pattern of eDCs in mice after allogeneic bone marrow transplantation by using bioluminescence imaging. eDCs were expanded from bone marrow precursors in the presence of GM-CSF, interleukin-4, and Flt3L and retrovirally transduced to express luciferase (luc) and green fluorescence protein (gfp). Flow cytometry showed polyclonal DC populations after expansion that consisted of CD11c+CD11b+ and CD11c-CD11b+ cells that co-expressed CD40, CD80, CD86, and MHCII. eDCs were functional in mixed lymphocyte reactions and produced tumor necrosis factor-alpha on phytohemagglutinin stimulation. The eDCs were then injected intravenously into BALB/c recipient mice that had received allogeneic bone marrow transplantation 6 weeks previously. On day 1 after transfer, eDCs were detected by bioluminescence imaging throughout the lungs and spleen. In the later course, signals were observed throughout thymus, lower abdomen, and spleen throughout a period of more than 42 days. Immunofluorescence microscopy confirmed CD11c positivity on the gfp+ donor cells, which localized in T-cell zones of mesenteric lymph nodes, Peyer's patches, spleen, and thymus. These findings are important for adoptive immunotherapies because they indicate that eDCs migrate efficiently in vivo and are capable of surviving long term.

Indexed as

Adjuvants, ImmunologicAnimalsBone Marrow TransplantationCell MovementCell SurvivalDendritic CellsFlow CytometryGranulocyte-Macrophage Colony-Stimulating FactorGreen Fluorescent ProteinsInterleukin-4LuciferasesLungLymph NodesLymphoid TissueMaleMembrane ProteinsAdjuvants, Immunologicflt3 ligand proteinGranulocyte-Macrophage Colony-Stimulating FactorGreen Fluorescent ProteinsInterleukin-4LuciferasesMembrane ProteinsTumor Necrosis Factor-alpha

Identifiers

PMID16251416
PMCPMC1603780
OpenAlexW2168061799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.